These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9935175)

  • 1. Prospective study on cervical neoplasia IV. Presence of HPV antibodies.
    Vonka V; Hamsíková E; Kanka J; Ludvíková V; Sapp M; Smahel M
    Int J Cancer; 1999 Jan; 80(3):365-8. PubMed ID: 9935175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
    Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
    Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic.
    Hamsíková E; Ludvíková V; Smahel M; Sapp M; Vonka V
    Int J Cancer; 1998 Aug; 77(5):689-94. PubMed ID: 9688300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antibodies against human papillomavirus type 16 E4 and E7 proteins in sera of patients with cervical neoplasias.
    Stoian M; Repanovici R
    Rev Roum Virol; 1994; 45(3-4):185-92. PubMed ID: 7619739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of serum antibodies to Ras and type 16 E4 proteins of human papillomavirus in patients with precancerous lesions of the uterine cervix.
    Pedroza-Saavedra A; Cruz A; Esquivel F; De La Torre F; Berumen J; Gariglio P; Gutiérrez L
    Arch Virol; 2000; 145(3):603-23. PubMed ID: 10795526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
    Lehtinen M; Pawlita M; Zumbach K; Lie K; Hakama M; Jellum E; Koskela P; Luostarinen T; Paavonen J; Pukkala E; Sigstad E; Thoresen S; Dillner J
    Am J Obstet Gynecol; 2003 Jan; 188(1):49-55. PubMed ID: 12548195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.
    Fujii T; Matsushima Y; Yajima M; Sugimura T; Terada M
    Jpn J Cancer Res; 1995 Jan; 86(1):28-34. PubMed ID: 7737906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
    Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
    Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Gallee MP; Hart AA; Müller M; Trimbos JB; Helmerhorst TJ
    Cancer; 1994 Oct; 74(8):2307-13. PubMed ID: 7922982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of serum antibodies to synthetic peptides to HPV16 epitopes among Indian women with cervical neoplasia.
    Sharma BK; Ray A; Murthy NS
    Eur J Cancer; 1996 May; 32A(5):872-6. PubMed ID: 9081369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.
    Jochmus I; Bouwes Bavinck JN; Gissmann L
    Mol Cell Probes; 1992 Aug; 6(4):319-25. PubMed ID: 1326715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls.
    Achour M; Zeghal D; Kochbati L; Kahla S; Zouari F; Maalej M; Oueslati R
    J Immunoassay Immunochem; 2008; 29(3):266-80. PubMed ID: 18569375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.
    Jochmus-Kudielka I; Schneider A; Braun R; Kimmig R; Koldovsky U; Schneweis KE; Seedorf K; Gissmann L
    J Natl Cancer Inst; 1989 Nov; 81(22):1698-704. PubMed ID: 2553991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.
    Krchnák V; Vágner J; Suchánková A; Krcmár M; Ritterová L; Vonka V
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2719-24. PubMed ID: 2174961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
    Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
    Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras.
    Ferrera A; Baay MF; Herbrink P; Figueroa M; Velema JP; Melchers WJ
    Int J Cancer; 1997 Dec; 73(6):781-5. PubMed ID: 9399651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls.
    Köchel HG; Monazahian M; Sievert K; Höhne M; Thomssen C; Teichmann A; Arendt P; Thomssen R
    Int J Cancer; 1991 Jul; 48(5):682-8. PubMed ID: 1649138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.
    Rocha-Zavaleta L; Jordan D; Pepper S; Corbitt G; Clarke F; Maitland NJ; Sanders CM; Arrand JR; Stern PL; Stacey SN
    Br J Cancer; 1997; 75(8):1144-50. PubMed ID: 9099962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.